XML 34 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Net sales $ 3,964.2 $ 3,802.1 $ 3,808.7
Cost of goods sold 2,580.0 2,492.4 2,470.8
Restructuring and related charges 14.3 2.8 3.6
Gross profit 1,369.9 1,306.9 1,334.3
Selling 614.5 600.5 607.2
General and administrative 337.8 354.6 335.8
Research and development 41.8 43.5 44.6
Restructuring and related charges 58.3 62.9 72.0
Transaction related charges 23.1 21.8 30.2
Loss on assets held for sale 26.8 0.0 0.0
Write-off from impairment of goodwill 0.0 116.0 0.0
Write-off from impairment of intangible assets 24.2 35.4 20.3
Total operating expenses 1,126.5 1,234.7 1,110.1
Operating income 243.4 72.2 224.2
Interest expense 144.5 222.1 264.0
Gain from extinguishment of Salus CLO debt (76.2) 0.0 0.0
Other non-operating expense (income), net 19.7 43.9 (4.1)
Income (loss) from continuing operations before income taxes 155.4 (193.8) (35.7)
Income tax expense (benefit) 70.9 (7.1) (462.7)
Net income (loss) from continuing operations 84.5 (186.7) 427.0
Income from discontinued operations, net of tax 14.0 682.5 445.0
Net income 98.5 495.8 872.0
Net income attributable to non-controlling interest 0.7 1.3 103.7
Net income attributable to controlling interest 97.8 494.5 768.3
Amounts attributable to controlling interest      
Net income (loss) from continuing operations attributable to controlling interest 83.8 (188.0) 356.5
Net (loss) income attributable to controlling interest from discontinued operations 14.0 682.5 411.8
Net income attributable to controlling interest $ 97.8 $ 494.5 $ 768.3
Earnings Per Share      
Basic earnings per share from continuing operations (in dollars per share) $ 1.88 $ (3.71) $ 9.64
Basic earnings per share from discontinued operations (in dollars per share) 0.31 13.47 11.15
Basic earnings per share (in dollars per share) 2.19 9.76 20.79
Diluted earnings per share from continuing operations (in dollars per share) 1.87 (3.71) 9.62
Diluted earnings per share from discontinued operations (in dollars per share) 0.31 13.47 11.12
Diluted earnings per share (in dollars per share) 2.18 9.76 20.74
Dividend per share (in dollars per share) $ 1.68 $ 1.68 $ 0.42
Weighted Average Shares Outstanding      
Basic (in shares) 44.7 50.7 36.9
Diluted (in shares) 44.9 50.7 37.0
SB/RH      
Net sales $ 3,964.2 $ 3,802.1 $ 3,808.7
Cost of goods sold 2,580.0 2,492.4 2,470.8
Restructuring and related charges 14.3 2.8 3.6
Gross profit 1,369.9 1,306.9 1,334.3
Selling 614.5 600.5 607.2
General and administrative 330.9 349.8 257.7
Research and development 41.8 43.5 44.6
Restructuring and related charges 58.3 62.9 72.0
Transaction related charges 23.1 21.8 30.2
Loss on assets held for sale 26.8 0.0 0.0
Write-off from impairment of goodwill 0.0 116.0 0.0
Write-off from impairment of intangible assets 24.2 35.4 20.3
Total operating expenses 1,119.6 1,229.9 1,032.0
Operating income 250.3 77.0 302.3
Interest expense 144.0 162.0 167.0
Other non-operating expense (income), net 19.7 44.2 5.2
Income (loss) from continuing operations before income taxes 86.6 (129.2) 130.1
Income tax expense (benefit) 58.1 10.7 (76.8)
Net income (loss) from continuing operations 28.5 (139.9) 206.9
Income from discontinued operations, net of tax 14.0 682.5 (24.0)
Net income 42.5 542.6 182.9
Net income attributable to non-controlling interest 0.7 1.3 1.4
Net income attributable to controlling interest 41.8 541.3 181.5
Amounts attributable to controlling interest      
Net income (loss) from continuing operations attributable to controlling interest 27.8 (141.2) 205.5
Net (loss) income attributable to controlling interest from discontinued operations 14.0 682.5 (24.0)
Net income attributable to controlling interest $ 41.8 $ 541.3 $ 181.5